Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenming Liu

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
European Journal of Medicinal Chemistry|August 22, 2019
Discovery of fused heterocyclic carboxamide derivatives as novel α7-nAChR agonists: Synthesis, preliminary SAR and biological evaluationYu Xue, Xiaomeng He, Taoyi Yang, et al.
Bioorganic & Medicinal Chemistry|June 18, 2015
New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compoundsYu Zhang, Bin Liu, Xingyu Wu, et al.
European Journal of Medicinal Chemistry|March 30, 2023
Design, synthesis and biological evaluation of dual Topo II/HDAC inhibitors bearing pyrimido[5,4-b]indole and pyrazolo[3,4-d]pyrimidine motifsMengmiao Zhao, Kan Yang, Xinyue Zhu, et al.
Journal of Medicinal Chemistry|July 4, 2019
Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative DiseasesXiaodong Dou, Huixia Huang, Yibo Li, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
Long-Term Bioavailability of Single Doses of Intramuscular Vitamin D<sub>2</sub>Feng Xu, Dexing Dai, Ruoman Sun, et al.
Signal Transduction and Targeted Therapy|February 9, 2023
Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancerXiaocong Pang, Xiaojiao Sun, Yanlun Gu, et al.
European Journal of Medicinal Chemistry|February 26, 2025
Design, synthesis, and antitumor activity of NSDs inhibitors targeting lung squamous cell carcinomaSiyu Xiu, Zhenyu Jia, Zhiqi Wang, et al.
European Journal of Medicinal Chemistry|March 28, 2024
Discovery of novel and selective farnesoid X receptor antagonists through structure-based virtual screening, preliminary structure-activity relationship study, and biological evaluationXiaodong Dou, Tongyu Huo, Yameng Liu, et al.
Journal of Medicinal Chemistry|October 24, 2024
Discovery of Potent and Selective Blockers Targeting the Epilepsy-Associated K<sub>Na</sub>1.1 ChannelRuqiu Zheng, Zhongtang Li, Qiufeng Wang, et al.
Journal of Medicinal Chemistry|May 26, 2026
Pyridoimidazolyl Sulfonamide Compound <b>2</b>: A Superior Dual-Acting Drug Candidate with Potent URAT1 Inhibition and Anti-Inflammatory Activity for Gout ManagementXiaoyu Shi, Cheng Shi, Mingyu Yang, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
European Journal of Medicinal Chemistry|August 22, 2019
Discovery of fused heterocyclic carboxamide derivatives as novel α7-nAChR agonists: Synthesis, preliminary SAR and biological evaluationYu Xue, Xiaomeng He, Taoyi Yang, et al.
Bioorganic & Medicinal Chemistry|June 18, 2015
New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compoundsYu Zhang, Bin Liu, Xingyu Wu, et al.
European Journal of Medicinal Chemistry|March 30, 2023
Design, synthesis and biological evaluation of dual Topo II/HDAC inhibitors bearing pyrimido[5,4-b]indole and pyrazolo[3,4-d]pyrimidine motifsMengmiao Zhao, Kan Yang, Xinyue Zhu, et al.
Journal of Medicinal Chemistry|July 4, 2019
Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative DiseasesXiaodong Dou, Huixia Huang, Yibo Li, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
Long-Term Bioavailability of Single Doses of Intramuscular Vitamin D<sub>2</sub>Feng Xu, Dexing Dai, Ruoman Sun, et al.
Signal Transduction and Targeted Therapy|February 9, 2023
Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancerXiaocong Pang, Xiaojiao Sun, Yanlun Gu, et al.
European Journal of Medicinal Chemistry|February 26, 2025
Design, synthesis, and antitumor activity of NSDs inhibitors targeting lung squamous cell carcinomaSiyu Xiu, Zhenyu Jia, Zhiqi Wang, et al.
European Journal of Medicinal Chemistry|March 28, 2024
Discovery of novel and selective farnesoid X receptor antagonists through structure-based virtual screening, preliminary structure-activity relationship study, and biological evaluationXiaodong Dou, Tongyu Huo, Yameng Liu, et al.
Journal of Medicinal Chemistry|October 24, 2024
Discovery of Potent and Selective Blockers Targeting the Epilepsy-Associated K<sub>Na</sub>1.1 ChannelRuqiu Zheng, Zhongtang Li, Qiufeng Wang, et al.
Journal of Medicinal Chemistry|May 26, 2026
Pyridoimidazolyl Sulfonamide Compound <b>2</b>: A Superior Dual-Acting Drug Candidate with Potent URAT1 Inhibition and Anti-Inflammatory Activity for Gout ManagementXiaoyu Shi, Cheng Shi, Mingyu Yang, et al.
Pageof 17